The role of bile acids in carcinogenesis T Režen, D Rozman, T Kovács, P Kovács, A Sipos, P Bai, E Mikó Cellular and molecular life sciences 79 (5), 243, 2022 | 176 | 2022 |
Cholesterol, lipoproteins, and COVID-19: Basic concepts and clinical applications E Kočar, T Režen, D Rozman Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids …, 2021 | 175 | 2021 |
Acrolein consumption induces systemic dyslipidemia and lipoprotein modification DJ Conklin, OA Barski, JF Lesgards, P Juvan, T Rezen, D Rozman, ... Toxicology and applied pharmacology 243 (1), 1-12, 2010 | 123 | 2010 |
Interplay between cholesterol and drug metabolism T Rezen, D Rozman, JM Pascussi, K Monostory Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1814 (1), 146-160, 2011 | 106 | 2011 |
Regulation of hepatic cytochromes p450 by lipids and cholesterol M Hafner, T Rezen, D Rozman Current drug metabolism 12 (2), 173-185, 2011 | 71 | 2011 |
Effect of CAR activation on selected metabolic pathways in normal and hyperlipidemic mouse livers T Režen, V Tamasi, A Lövgren-Sandblom, I Björkhem, UA Meyer, ... BMC genomics 10, 1-15, 2009 | 66 | 2009 |
New aspects on lanosterol 14α-demethylase and cytochrome P450 evolution: lanosterol/cycloartenol diversification and lateral transfer T Režen, N Debeljak, D Kordiš, D Rozman Journal of molecular evolution 59, 51-58, 2004 | 65 | 2004 |
MicroRNA in skeletal muscle development, growth, atrophy, and disease A Kovanda, T Režen, B Rogelj Wiley Interdisciplinary Reviews: RNA 5 (4), 509-525, 2014 | 63 | 2014 |
Expression changes in human skeletal muscle mi RNA s following 10 days of bed rest in young healthy males T Režen, A Kovanda, O Eiken, IB Mekjavic, B Rogelj Acta Physiologica 210 (3), 655-666, 2014 | 53 | 2014 |
Cholesterogenic Lanosterol 14α-Demethylase (CYP51) Is an Immediate Early Response Gene M Fink, J Ačimovič, T Režen, N Tanšek, D Rozman Endocrinology 146 (12), 5321-5331, 2005 | 43 | 2005 |
The human primary hepatocyte transcriptome reveals novel insights into atorvastatin and rosuvastatin action M Hafner, P Juvan, T Rezen, K Monostory, JM Pascussi, D Rozman Pharmacogenetics and genomics 21 (11), 741-750, 2011 | 37 | 2011 |
Oxysterols and gastrointestinal cancers around the clock U Kovač, C Skubic, L Bohinc, D Rozman, T Režen Frontiers in endocrinology 10, 483, 2019 | 35 | 2019 |
Network and systems medicine: Position paper of the european collaboration on science and technology action on open multiscale systems medicine B Comte, J Baumbach, A Benis, J Basílio, N Debeljak, Å Flobak, ... Network and systems medicine 3 (1), 67-90, 2020 | 30 | 2020 |
The Sterolgene v0 cDNA microarray: a systemic approach to studies of cholesterol homeostasis and drug metabolism T Režen, P Juvan, K Fon Tacer, D Kuzman, A Roth, D Pompon, ... BMC genomics 9, 1-15, 2008 | 27 | 2008 |
Acrolein‐induced dyslipidemia and acute‐phase response are independent of HMG‐CoA reductase DJ Conklin, RA Prough, P Juvan, T Rezen, D Rozman, P Haberzettl, ... Molecular nutrition & food research 55 (9), 1411-1422, 2011 | 25 | 2011 |
Identification of variants associated with rare hematological disorder erythrocytosis using targeted next-generation sequencing analysis A Kristan, T Pajič, A Maver, T Režen, T Kunej, R Količ, A Vuga, M Fink, ... Frontiers in Genetics 12, 689868, 2021 | 19 | 2021 |
Guided extraction of genome-scale metabolic models for the integration and analysis of omics data A Walakira, D Rozman, T Režen, M Mraz, M Moškon Computational and structural biotechnology journal 19, 3521-3530, 2021 | 19 | 2021 |
Obesity resistant mechanisms in the Lean polygenic mouse model as indicated by liver transcriptome and expression of selected genes in skeletal muscle M Simončič, T Režen, P Juvan, D Rozman, G Fazarinc, C Fievet, B Staels, ... BMC genomics 12, 1-12, 2011 | 19 | 2011 |
The impact of cholesterol and its metabolites on drug metabolism T Režen Expert Opinion on Drug Metabolism & Toxicology 7 (4), 387-398, 2011 | 18 | 2011 |
Functional genomics approaches to studies of the cytochrome p450 superfamily T Režen, JA Contreras, D Rozman Drug metabolism reviews 39 (2-3), 389-399, 2007 | 15 | 2007 |